Mobile Health Technology (mDiab) for the Prevention of Type 2 Diabetes: Protocol for a Randomized Controlled Trial
Open accessThe DOI matches its Crossref record; 15 of the 15 references it cites were found in a registry or an index.
Abstract
BACKGROUND: The prevalence of type 2 diabetes is increasing in epidemic proportions in low- and middle-income countries. There is an urgent need for novel methods to tackle the increasing incidence of diabetes. The ubiquity of mobile phone use and access to Internet makes mobile health (mHealth) technology a viable tool to prevent and manage diabetes. OBJECTIVE: The objective of this randomized controlled trial is to implement and evaluate the feasibility, cost-effectiveness, and sustainability of a reality television-based lifestyle intervention program. This intervention program is delivered via a mobile phone app (mDiab) to approximately 1500 Android smartphone users who are adults at a high risk for type 2 diabetes from three cities in India, namely, Chennai, Bengaluru, and New Delhi. METHODS: The mDiab intervention would be delivered via a mobile phone app along with weekly coach calls for 12 weeks. Each participant will go through a maintenance phase of 6 to 8 months post intervention. Overall, there would be 3 testing time points in the study: baseline, post intervention, and the end of follow-up. The app will enable individuals to track their weight, physical activity, and diet alongside weekly video lessons on type 2 diabetes prevention. RESULTS: The study outcomes are weight loss (primary measure of effectiveness); improvement in cardiometabolic risk factors (ie, waist circumference, blood pressure, glucose, insulin, and lipids); and improvement in physical activity, quality of life, and dietary habits. Sustainability will be assessed through focus group discussions. CONCLUSIONS: If successful, mDiab can be used as a model for translational and implementation research in the use of mHealth technology for diabetes prevention and may be further expanded for the prevention of other noncommunicable diseases such as hypertension and cardiovascular diseases. TRIAL REGISTRATION: Clinical Trials Registry of India CTRI/2015/07/006011 http://ctri.nic.in/Clinicaltrials/pdf_generate.php? trialid=11841 (Archived by WebCite at http://www.webcitation.org/6urCS5kMB).
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Reduction in the incidence of type 2 diabetes with lifestyle intervention or metformin
(2002) · New England Journal of Medicine · doi:10.1056/nejmoa012512 · Cited by 19,011
Ramachandran, A., Snehalatha, C., Mary, S., Mukesh, B., Bhaskar, A. D., Vijay, V., & Indian Diabetes Prevention Programme (IDPP) (2006) · Diabetologia · doi:10.1007/s00125-005-0097-z · Cited by 1,881
The Finnish Diabetes Prevention Study (DPS)
Lindström, J., Louheranta, A., Mannelin, M., Rastas, M., Salminen, V., Eriksson, J., Uusitupa, M., Tuomilehto, J., & for the Finnish Diabetes Prevention Study Group (2003) · Diabetes Care · doi:10.2337/diacare.26.12.3230 · Cited by 1,848
Gillies, C. L., Abrams, K. R., Lambert, P. C., Cooper, N. J., Sutton, A. J., Hsu, R. T., & Khunti, K. (2007) · BMJ · doi:10.1136/bmj.39063.689375.55 · Cited by 1,171 · cited 1×
“Several randomized controlled trials (RCTs) carried out on primary prevention of T2DM have shown that lifestyle modification and metformin therapy can reduce the incidence of T2DM in people who are in the prediabetes stage, that is, those having impaired glucose tolerance (IGT) or impaired fasting glucose (IFG), or bo…”
Objectively Measured Sedentary Time, Physical Activity, and Metabolic Risk
Healy, G. N., Wijndaele, K., Dunstan, D. W., Shaw, J. E., Salmon, J., Zimmet, P. Z., & Owen, N. (2008) · Diabetes Care · doi:10.2337/dc07-1795 · Cited by 1,100
Diabetes: a 21st century challenge
Zimmet, P. Z., Magliano, D. J., Herman, W. H., & Shaw, J. E. (2014) · The Lancet Diabetes & Endocrinology · doi:10.1016/s2213-8587(13)70112-8 · Cited by 1,062
Physical Activity and Television Watching in Relation to Risk for Type 2 Diabetes Mellitus in Men
Hu, F. B., Leitzmann, M. F., Stampfer, M. J., Colditz, G. A., Willett, W. C., & Rimm, E. B. (2001) · Archives of Internal Medicine · doi:10.1001/archinte.161.12.1542 · Cited by 828 · cited 1×
“Studies in different populations have shown that a large part of T2DM is attributed to factors such as obesity (both generalized and abdominal), sedentary lifestyle, and poor diet [4-7].”
Prevention of type 2 diabetes by lifestyle intervention: a Japanese trial in IGT males
Kosaka, K., Noda, M., & Kuzuya, T. (2005) · Diabetes Research and Clinical Practice · doi:10.1016/j.diabres.2004.06.010 · Cited by 656
Labrique, A. B., Vasudevan, L., Kochi, E., Fabricant, R., & Mehl, G. (2013) · Global Health: Science and Practice · doi:10.9745/ghsp-d-13-00031 · Cited by 601 · cited 1×
“This massive upswing and uptake of technology in the field of mobile technology renders mHealth as a liable opportunity to provide individual-level support beyond traditional clinic-based care technology [17,20-24].”
Chomutare, T., Fernandez-Luque, L., Årsand, E., & Hartvigsen, G. (2011) · Journal of Medical Internet Research · doi:10.2196/jmir.1874 · Cited by 451
Cited by
Engagement and weight loss: results from the Mobile Health and Diabetes Trial
Muralidharan, S., Ranjani, H., Mohan Anjana, R., Jena, S., Tandon, N., Gupta, Y., Ambekar, S., Koppikar, V., Jagannathan, N., Allender, S., et al. (2019) · Diabetes Technology & Therapeutics · doi:10.1089/dia.2019.0134 · Cited by 42
Self-citationMuralidharan, S., Ranjani, H., Anjana, R. M., Gupta, Y., Ambekar, S., Koppikar, V., Jagannathan, N., Jena, S., Tandon, N., Allender, S., et al. (2021) · DIGITAL HEALTH · doi:10.1177/20552076211039032 · Cited by 22
Self-citationHan, C.-Y., Zhang, J., Ye, X.-M., Lu, J.-P., Jin, H.-Y., Xu, W.-W., Wang, P., & Zhang, M. (2023) · BMC Medical Informatics and Decision Making · doi:10.1186/s12911-023-02283-4 · Cited by 19
“Evidence of such efficacy might impact the overall burden of the disease by reducing the unnecessary use of healthcare resources [18].”
BackgroundSun, Y.-Q., Jia, Y.-P., Lv, J.-Y., & Ma, G.-J. (2020) · Cardiovascular Diagnosis and Therapy · doi:10.21037/cdt-20-589 · Cited by 18
“With the rapid development of networking and mobile Internet use, mobile information technology provides opportunities for online medical services (12).”
Background
Metadata
- Authors
- Muralidharan, S., Mohan, V., Anjana, R. M., Jena, S., Tandon, N., Allender, S., & Ranjani, H.
- Venue
- JMIR Research Protocols
- Publisher
- JMIR Publications Inc.
- Published
- 2017-12-12
- Volume
- 6
- Issue
- 12
- Pages
- e242
- ISSN
- 1929-0748 (ISSN-L)
- OpenAlex
- W2774391870
- Cited by
- 26
- References
- 15
- FWCI
- 6.62
- Type
- journal article
- Language
- en
- Open access
- gold
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
How to cite
Cite CoChat for the checks on this page, and the paper for its own findings.
- This page
- CoChat. (2026). Citation check: Mobile Health Technology (mDiab) for the Prevention of Type 2 Diabetes: Protocol for a Randomized Controlled Trial. https://app.cochat.ai/papers/10.2196/resprot.8644
- The paper
- Muralidharan, S., Mohan, V., Anjana, R. M., Jena, S., Tandon, N., Allender, S., & Ranjani, H. (2017). Mobile Health Technology (mDiab) for the Prevention of Type 2 Diabetes: Protocol for a Randomized Controlled Trial. JMIR Research Protocols. https://doi.org/10.2196/resprot.8644
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.